Cargando…
Ion Channel Drugs Suppress Cancer Phenotype in NG108-15 and U87 Cells: Toward Novel Electroceuticals for Glioblastoma
SIMPLE SUMMARY: Glioblastoma is a rapidly progressing brain cancer that is very difficult to treat. Given that many aspects of cell and tissue behavior are controlled by electric signaling, we sought to test whether drugs that target ion channel proteins might be effective at controlling the spread...
Autores principales: | Mathews, Juanita, Kuchling, Franz, Baez-Nieto, David, Diberardinis, Miranda, Pan, Jen Q., Levin, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8946312/ https://www.ncbi.nlm.nih.gov/pubmed/35326650 http://dx.doi.org/10.3390/cancers14061499 |
Ejemplares similares
-
Different modes of growth cone collapse in NG 108-15 cells
por: Rauch, Philipp, et al.
Publicado: (2013) -
Proteomics Analysis of Normal and Senescent NG108-15 Cells: GRP78 Plays a Negative Role in Cisplatin-Induced Senescence in the NG108-15 Cell Line
por: Li, Wei, et al.
Publicado: (2014) -
Inhibition of U-87 MG glioblastoma by AN-152 (AEZS-108), a targeted cytotoxic analog of luteinizing hormone-releasing hormone
por: Jaszberenyi, Miklos, et al.
Publicado: (2013) -
Netupitant and palonosetron trigger NK(1) receptor internalization in NG108-15 cells
por: Thomas, Ajit G., et al.
Publicado: (2014) -
Nogo-A/NgR signaling regulates stemness in cancer stem-like cells derived from U87MG glioblastoma cells
por: Ai, Chengjin, et al.
Publicado: (2022)